Heart Failure Comorbidities

HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s
HFA 2026: UF-CARE — Ultrafiltration in Type 2 Cardiorenal Syndrome

Guillaume Baudry

Watch time: 5m 55s

Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado

Read time: 28m 20s

Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al

Read time: 31m 40s

Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al

Read time: 26m 40s
ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s

Nikhil Ahluwalia, Shohreh Honarbakhsh, Ross Hunter, et al

Read time: 25m

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

February’s Top 10 Cardiology Resources: Videos and Essential Reads

Radcliffe Cardiology

Nadirah Abd Wahid, Aisya Natasya Musa, Sazzli Kasim, et al

Read time: 30m
Delayed ATTR-CM Diagnosis Common in HF Patients

Radcliffe Cardiology

Andrew JS Coats, Stefan Anker

 Ep 146: The Heart Function Revolution: Why Prevention Matters

Listen time: 37m 49s
ESC 24 in Review with Dr Purvi Parwani

Listen time: 1h 6m 14s
Ep 151: Cardiology's 2025 Year in Review with Dr Sukh Nijjer

Listen time: 1h 40m 44s

Antonio Méndez-Durán, Juan B Ivey-Miranda, Genaro H Mendoza-Zavala, et al

Read time: 26m 40s

Bahira Shahim, Chris J Kapelios, Gianluigi Savarese, et al

Read time: 18m

Fausto J Pinto, John Spertus, , et al

Watch time: 2s (19 videos)

Shubh K Patel, Hwee Teoh, Ahreni Saunthar, et al

Read time: 24m 34s

Ovidiu Chioncel, Alexandre Mebazaa, Sean P Collins, et al

Read time: 31m 40s

Victoria Delgado, Laura Sanchis, Julia Grapsa, et al

Harriette Van Spall, Stefan James

Daniel Escribano, Elena Díaz-Peláez, Victoria Delgado

Read time: 28m 20s

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

Broadcast

Heart Failure
e-SPACE HF 2024 – Day Two

Clara Saldarriaga, Gianluigi Savarese, Javed Butler

Broadcast

Heart Failure
e-SPACE HF 2024 – Day One

Clara Saldarriaga, Gianluigi Savarese, Javed Butler

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)

Broadcast

Guidelines & Statements

Heart Failure
Guideline Controversies

Watch time: 3h 27m 5s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: The HEART-FID Study

Robert Mentz

Watch time: 3m 59s
HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s
HFA 23 Late-breaker Discussion: The PARAGLIDE-HF Trial

Robert Mentz, Harriette Van Spall

Watch time: 5m 48s

Broadcast

Guidelines & Statements

Heart Failure
e-SPACE HF 2023 – Day Two

William T Abraham, Marianna Adamo, Stefan Anker , et al

Broadcast

Heart Failure
e-SPACE HF 2023 – Day One

William T Abraham, Marianna Adamo, Stefan Anker , et al

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 18m (7 videos)

Media

HFA 2026: UF-CARE — Ultrafiltration in Type 2 Cardiorenal Syndrome

Guillaume Baudry

Watch time: 5m 55s
HFA 2026: Obesity and Natriuretic Peptides in Heart Failure — PORTHOS

Rui Baptista

Watch time: 8m 12s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D

Steven E Nissen

Watch time: 4m 47s

Javed Butler, Dinesh Khullar, John JV McMurray, et al

Watch time: 59m 13s (5 videos)
AHA 2025: The TIRZSEMA-CVOT Study

Nils Krüger

Watch time: 5m 49s
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s

Broadcast

CV Disease in Special Populations

Heart Failure
Recovery of Anthracycline-Induced Cardiomyopathy

Joe Carver, Osnat Itzhaki Ben Zadok, Jose Álvarez-Cardona

Watch time: 54m 49s

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s

Articles

Severe Aortic Stenosis and Heart Failure

Ernest Spitzer

,

Rebecca T Hahn

,

Philippe Pibarot

,

Ton de Vries

,

Jeroen J Bax

,

Martin B Leon

,

Nicolas M Van Mieghem

,

Published:

24 May 2019

Citation:

Cardiac Failure Review 2019;5(2):99–105.

DOI:

https://doi.org/10.15420/cfr.2018.41.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 28
  • Citations: 29

Heart Failure and Frailty Syndrome

Izabella Uchmanowicz

,

Agnieszka Młynarska

,

Magdalena Lisiak

,

Marta Kałuzna-Oleksy

,

Marta Wleklik

,

Anna Chudiak

,

Magdalena Dudek

,

Jacek Migaj

,

Lynne Hinterbuchner

,

Robbert Gobbens

,

Published:

11 February 2019

Citation:

Cardiac Failure Review 2019;5(1):37–43.

DOI:

https://doi.org/10.15420/cfr.2018.37.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 35
  • Citations: 45

Subclinical Left Ventricular Dysfunction During Chemotherapy

Martin Nicol

,

Mathilde Baudet

,

Alain Cohen-Solal

,

Published:

11 February 2019

Citation:

Cardiac Failure Review 2019;5(1):31–6.

DOI:

https://doi.org/10.15420/cfr.2018.25.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 35
  • Citations: 29

Treatment of Heart Failure with Anti-diabetic Drugs

Thomas A Zelniker

,

Eugene Braunwald

,

Published:

11 February 2019

Citation:

Cardiac Failure Review 2019;5(1):27–30.

DOI:

https://doi.org/10.15420/cfr.2018.44.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Downloads: Downloads 39
  • Citations: 11